Skip to content
★ Sign in to follow
GC

Gocalves Cacela Matias S.

CEO
Vivoryon Therapeutics N.V.
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€84k
▼ Sales (0 ops.)
—

Latest filing: trade of 02 Nov 2023 for Vivoryon Therapeutics N.V., €84k. The register gives no publication date.

Filing timeline

BuySale
Gocalves Cacela Matias S.

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Gocalves Cacela Matias S.: trading record in brief

One trade, one date: on 7 November 2023, Gocalves Cacela Matias S. disclosed an open-market purchase of €84k in Vivoryon Therapeutics N.V. No broader history exists yet. Source: insider filings from AFM. Past trades are no guide to future returns.

Companies and markets linked to Gocalves Cacela Matias S.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Person closely associated with Weber F. (CEO)ExecutivesAFM delayVivoryon Therapeutics N.V.
    €84k42AFM-MAR19
    10,600 shares@ €7.90100.0% of flowGewoon aandeelEURONEXT - EURONEXT AMSTERDAMISIN NL00150002Q7AFM:MAR19:202311020F33F9D2-1D7A-EE11-A309-005056BB4E9F
    Canonical exit: 31 Jan 2024 (T+90)

1 of 1 declaration